Familial risk of Sjögren's syndrome and co-aggregation of autoimmune diseases in affected families: a nationwide population study

Objective: To investigate familial aggregation of Sjögren's syndrome (SS) and the relative risks (RRs) of other autoimmune disease in relatives of patients with SS. Methods: We identified 23,658,577 beneficiaries enrolled in the Taiwan National Health Insurance system in 2010, of whom 12,754...

Full description

Bibliographic Details
Main Authors: Kuo, Chang-Fu, Grainge, Matthew J., Valdes, Ana M., See, Lai-Chu, Luo, Shue-Fen, Yu, Kuang-Hui, Zhang, Weiya, Doherty, Michael
Format: Article
Published: Wiley 2015
Online Access:https://eprints.nottingham.ac.uk/35897/
_version_ 1848795185574576128
author Kuo, Chang-Fu
Grainge, Matthew J.
Valdes, Ana M.
See, Lai-Chu
Luo, Shue-Fen
Yu, Kuang-Hui
Zhang, Weiya
Doherty, Michael
author_facet Kuo, Chang-Fu
Grainge, Matthew J.
Valdes, Ana M.
See, Lai-Chu
Luo, Shue-Fen
Yu, Kuang-Hui
Zhang, Weiya
Doherty, Michael
author_sort Kuo, Chang-Fu
building Nottingham Research Data Repository
collection Online Access
description Objective: To investigate familial aggregation of Sjögren's syndrome (SS) and the relative risks (RRs) of other autoimmune disease in relatives of patients with SS. Methods: We identified 23,658,577 beneficiaries enrolled in the Taiwan National Health Insurance system in 2010, of whom 12,754 had SS. We identified 21,009,551 parent–child relationships and 17,168,340 pairs of full siblings. The familial risks of SS and other autoimmune diseases, tetrachoric correlation, and familial transmission were estimated. Results: We identified 105 patients with SS who had an affected first-degree relative. The RR of SS was 18.99 (95% confidence interval [95% CI] 9.76–36.93) in siblings of patients with SS, 11.31 (95% CI 8.34–15.33) in offspring, and 12.46 (95% CI 9.34–16.62) in parents. Tetrachoric correlation coefficients were 0.53 (95% CI 0.41–0.65) for cotwins of affected individuals and 0.21 (95% CI 0.16–0.26) for full siblings. The familial transmission (heritability plus shared environmental contribution) was 0.54 (95% CI 0.44–0.77). In first-degree relatives of patients with SS, the RRs were 2.95 (95% CI 2.33–3.73) for rheumatoid arthritis, 6.25 (95% CI 5.15–7.58) for systemic lupus erythematosus, 2.39 (95% CI 0.77–7.41) for systemic sclerosis, 0.71 (95% CI 0.10–5.07) for idiopathic inflammatory myopathy, 1.97 (95% CI 1.29–3.02) for type 1 diabetes mellitus, 3.38 (95% CI 1.26–9.05) for multiple sclerosis, 1.67 (95% CI 0.83–3.33) for myasthenia gravis, 1.25 (95% CI 1.04–1.50) for psoriasis, 1.21 (95% CI 0.39–3.76) for inflammatory bowel disease, and 2.29 (95% CI 1.19–4.40) for vasculitis. Conclusion: The risk of SS and other autoimmune diseases is increased in relatives of patients with SS, and more than one-half of phenotypic variance in SS can be explained by familial factors.
first_indexed 2025-11-14T19:28:04Z
format Article
id nottingham-35897
institution University of Nottingham Malaysia Campus
institution_category Local University
last_indexed 2025-11-14T19:28:04Z
publishDate 2015
publisher Wiley
recordtype eprints
repository_type Digital Repository
spelling nottingham-358972020-05-04T17:09:55Z https://eprints.nottingham.ac.uk/35897/ Familial risk of Sjögren's syndrome and co-aggregation of autoimmune diseases in affected families: a nationwide population study Kuo, Chang-Fu Grainge, Matthew J. Valdes, Ana M. See, Lai-Chu Luo, Shue-Fen Yu, Kuang-Hui Zhang, Weiya Doherty, Michael Objective: To investigate familial aggregation of Sjögren's syndrome (SS) and the relative risks (RRs) of other autoimmune disease in relatives of patients with SS. Methods: We identified 23,658,577 beneficiaries enrolled in the Taiwan National Health Insurance system in 2010, of whom 12,754 had SS. We identified 21,009,551 parent–child relationships and 17,168,340 pairs of full siblings. The familial risks of SS and other autoimmune diseases, tetrachoric correlation, and familial transmission were estimated. Results: We identified 105 patients with SS who had an affected first-degree relative. The RR of SS was 18.99 (95% confidence interval [95% CI] 9.76–36.93) in siblings of patients with SS, 11.31 (95% CI 8.34–15.33) in offspring, and 12.46 (95% CI 9.34–16.62) in parents. Tetrachoric correlation coefficients were 0.53 (95% CI 0.41–0.65) for cotwins of affected individuals and 0.21 (95% CI 0.16–0.26) for full siblings. The familial transmission (heritability plus shared environmental contribution) was 0.54 (95% CI 0.44–0.77). In first-degree relatives of patients with SS, the RRs were 2.95 (95% CI 2.33–3.73) for rheumatoid arthritis, 6.25 (95% CI 5.15–7.58) for systemic lupus erythematosus, 2.39 (95% CI 0.77–7.41) for systemic sclerosis, 0.71 (95% CI 0.10–5.07) for idiopathic inflammatory myopathy, 1.97 (95% CI 1.29–3.02) for type 1 diabetes mellitus, 3.38 (95% CI 1.26–9.05) for multiple sclerosis, 1.67 (95% CI 0.83–3.33) for myasthenia gravis, 1.25 (95% CI 1.04–1.50) for psoriasis, 1.21 (95% CI 0.39–3.76) for inflammatory bowel disease, and 2.29 (95% CI 1.19–4.40) for vasculitis. Conclusion: The risk of SS and other autoimmune diseases is increased in relatives of patients with SS, and more than one-half of phenotypic variance in SS can be explained by familial factors. Wiley 2015-06-26 Article PeerReviewed Kuo, Chang-Fu, Grainge, Matthew J., Valdes, Ana M., See, Lai-Chu, Luo, Shue-Fen, Yu, Kuang-Hui, Zhang, Weiya and Doherty, Michael (2015) Familial risk of Sjögren's syndrome and co-aggregation of autoimmune diseases in affected families: a nationwide population study. Arthritis & Rheumatology, 67 (7). pp. 1904-1912. ISSN 2326-5205 http://onlinelibrary.wiley.com/doi/10.1002/art.39127/abstract doi:10.1002/art.39127 doi:10.1002/art.39127
spellingShingle Kuo, Chang-Fu
Grainge, Matthew J.
Valdes, Ana M.
See, Lai-Chu
Luo, Shue-Fen
Yu, Kuang-Hui
Zhang, Weiya
Doherty, Michael
Familial risk of Sjögren's syndrome and co-aggregation of autoimmune diseases in affected families: a nationwide population study
title Familial risk of Sjögren's syndrome and co-aggregation of autoimmune diseases in affected families: a nationwide population study
title_full Familial risk of Sjögren's syndrome and co-aggregation of autoimmune diseases in affected families: a nationwide population study
title_fullStr Familial risk of Sjögren's syndrome and co-aggregation of autoimmune diseases in affected families: a nationwide population study
title_full_unstemmed Familial risk of Sjögren's syndrome and co-aggregation of autoimmune diseases in affected families: a nationwide population study
title_short Familial risk of Sjögren's syndrome and co-aggregation of autoimmune diseases in affected families: a nationwide population study
title_sort familial risk of sjögren's syndrome and co-aggregation of autoimmune diseases in affected families: a nationwide population study
url https://eprints.nottingham.ac.uk/35897/
https://eprints.nottingham.ac.uk/35897/
https://eprints.nottingham.ac.uk/35897/